Mon Mar 2 00:36:36 SGT 2015  
    Hepatitis B, Philippines
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment
28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing

Hepatitis B, Philippines


Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference

Latest News

Hepatitis B virus infection in children
Sat, 28 Feb 2015 04:29:26 +0100 | Expert Review of Anti-Infective Therapy
Expert Review of Anti-infective Therapy, Ahead of Print. (Source: Expert Review of Anti-Infective Therapy)

Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey
Sat, 28 Feb 2015 00:00:00 +0100 | Harm Reduction Journal

The Oral Toll-Like Receptor-7 Agonist GS-9620 in Patients with Chronic Hepatitis B Virus Infection
Sat, 28 Feb 2015 00:00:00 +0100 | Journal of Hepatology
GS-9620 is an oral agonist of toll-like receptor 7, a pattern-recognition receptor whose activation results in innate and adaptive immune stimulation. We evaluated the safety, pharmacokinetics, and pharmacodynamics of GS-9620 in patients with chronic hepatitis B. (Source: Journal of Hepatology)

Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
Fri, 27 Feb 2015 12:13:49 +0100 | Gut and Liver
Conclusions: HBsAg quantification using IRMA might be useful for discriminating different CHB phases and different stages of chronic liver disease.

Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case‐control study in The Gambia
Fri, 27 Feb 2015 11:58:31 +0100 | Liver International
ConclusionsCompared to controls, HCC cases had earlier birth order, a proxy for young maternal age and maternal HBV viraemia at birth. This finding suggests that in chronic HBV carriers perinatal mother‐to‐infant transmission may increase HCC risk more than horizontal transmission. Providing HBV vaccine within 24 hours of birth to interrupt perinatal transmission might reduce the incidence of HCC in The Gambia.This article is protected by copyright. All rights reserved. (Source: Liver International)

Impact of hepatitis B and C infections in renal transplantation
Fri, 27 Feb 2015 00:00:00 +0100 | Indian Journal of Transplantation
Publication date: October–December 2014 Source:Indian Journal of Transplantation, Volume 8, Issue 4 Author(s): Radhika Chemmangattu Radhakrishnan , Gopal Basu , Santhosh Varughese , Anjali Mahopatra , Anna. T. Valson , Suceena Alexander , Shibu Jacob , Harish Ratnakarrao Pathak , Uday Zaccharia , Priya Abraham , V. Tamilarasi (Source: Indian Journal of Transplantation)

Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study
Fri, 27 Feb 2015 00:00:00 +0100 | BMC Public Health

A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome
Fri, 27 Feb 2015 00:00:00 +0100 | Hepatology
Conclusion: In a high HIV burden area, drug‐induced liver injury due to antiretroviral therapy and cotrimoxazole was a frequent clinicopathological finding; Mycobacterium tuberculosis was the leading opportunistic infection, with more than half of patients fulfilling criteria for tuberculosis immune reconstitution syndrome; liver biopsy remains a useful diagnostic procedure in this setting. (Hepatology 2015) (Source: Hepatology)

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)
Fri, 27 Feb 2015 00:00:00 +0100 | Hepatology
Conclusion: Although the primary endpoint was not reached, 24 weeks of Peg‐IFN add‐on therapy led to a higher proportion of HBeAg response, compared to ETV monotherapy. Add‐on therapy resulted in more viral decline and appeared to prevent relapse after stopping ETV. Hence, Peg‐IFN add‐on therapy may facilitate the discontinuation of nucleos(t)ide analogs. (Hepatology 2014) (Source: Hepatology)

Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
Fri, 27 Feb 2015 00:00:00 +0100 | Molecular Therapy
Authors: Anette Brass, Lars Frelin, David R Milich, Matti Sällberg & Gustaf Ahlén (Source: Molecular Therapy)